Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2372041309
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by King, A. D.
Right arrow Articles by van Hasselt, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, A. D.
Right arrow Articles by van Hasselt, A. C.
(Radiology 2005;237:563-569.)
© RSNA, 2005


Head and Neck Imaging

Salivary Gland Tumors at in Vivo Proton MR Spectroscopy1

Ann D. King, FRCR, David K. W. Yeung, PhD, Anil T. Ahuja, FRCR, Gary M. K. Tse, FRCPC, H. Y. Yuen, FRCR, K. T. Wong, FRCR and Andrew C. van Hasselt, MMed (Otol)

1 From the Department of Diagnostic Radiology and Organ Imaging (A.D.K., D.K.W.Y., A.T.A., H.Y.Y., K.T.W.), Department of Anatomical and Cellular Pathology (G.M.K.T.), and Department of Surgery (A.C.v.H.), Faculty of Medicine, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China. Received July 28, 2004; revision requested October 6; revision received October 20; accepted December 10. Address correspondence to A.D.K. (e-mail: b834756{at}mailserv.cuhk.hk).

PURPOSE: To prospectively evaluate whether proton magnetic resonance (MR) spectroscopy can be used to characterize salivary gland tumors (SGTs).

MATERIALS AND METHODS: Ethics committee approval and informed consent were obtained. Hydrogen 1 (1H) MR spectroscopy was performed with echo times of 136 and 272 msec at 1.5 T in both SGTs and normal parotid glands. Spectra were analyzed in the time domain by using prior knowledge in the fitting procedure to obtain peak amplitudes of choline (Cho), creatine (Cr), and unsuppressed water. Mean Cho/Cr and Cho/water ratios for each subgroup of SGTs were obtained, and results were compared by using a nonparametric t test.

RESULTS: Successful spectra were acquired in 56 patients (35 men, 21 women; mean age, 56 years) with a total of nine malignant tumors and 47 benign SGTs (24 Warthin tumors, 22 pleomorphic adenomas, one oncocytoma). At an echo time of 136 msec, Cho/Cr ratios were obtained in 26 (47%) of 55 spectra, with a mean value (± standard deviation) of 1.73 ± 0.47, 5.49 ± 1.86, 3.46 ± 0.84, and 2.45 for malignant tumors, Warthin tumors, pleomorphic adenomas, and oncocytoma, respectively. Differences were significant between Warthin tumors and pleomorphic adenomas (P = .028) and between benign SGTs and malignant tumors (P < .001). At an echo time of 272 msec, Cho/Cr ratios were obtained in 16 (30%) of 53 spectra, with a mean value of 2.27 ± 0.69, 6.92 ± 1.47, and 3.67 ± 1.23 for malignant tumors, Warthin tumors, and pleomorphic adenomas, respectively. Differences were also significant between Warthin tumors and pleomorphic adenomas (P = .041) and benign SGTs and malignant tumors (P = .004). There was a significant difference in mean Cho/water ratio for Warthin tumors versus pleomorphic adenomas at echo times of 136 msec (P = .003) and 272 msec (P = .002) but not for benign SGTs versus malignant tumors.

CONCLUSION: 1H MR spectroscopy may be used to characterize SGTs, but a larger study is required to validate these initial results.

© RSNA, 2005




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
Q. Yu, J. Yang, and P. Wang
Malignant Tumors and Chronic Infections in the Masticator Space: Preliminary Assessment with In Vivo Single-Voxel 1H-MR Spectroscopy
AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 716 - 719.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. F. Faria, S. M. Goldman, J. Szejnfeld, H. Melo, C. Kater, P. Kenney, M. P. Huayllas, G. Demarchi, V. V. Francisco, C. Andreoni, et al.
Adrenal Masses: Characterization with in Vivo Proton MR Spectroscopy Initial Experience
Radiology, December 1, 2007; 245(3): 788 - 797.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2005 by the Radiological Society of North America.